VERVE THERAPEUTICS INC (VERV)

US92539P1012 - Common Stock

6.41  +0.26 (+4.23%)

After market: 6.41 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
11.76M1.94M0.000.000.00
Operating Expenses
234.88M167.63M87.07M40.63M13.64M
Research and Development
184.95M130.10M68.20M35.37M11.14M
Selling, General, and Administrative Expenses
49.94M37.53M18.87M5.26M2.50M
Operating Income
-223.12M-165.69M-87.07M-40.63M-13.64M
Interest Income/Expense
23.17M6.87M140.00K160.00K280.00K
Other Income/Expense
165.00K1.49M-33.39M-5.24M-5.93M
Income Before Taxes
-199.79M-157.33M-120.31M-45.70M-19.30M
Income Tax
275.00K50.00KN/AN/AN/A
Net Income
-200.07M-157.39M-120.31M-45.70M-19.30M
EBITDA
-217.67M-162.89M-85.53M-39.30M-13.53M
 
Per Share Data
EPS Diluted Total Ops
-3.12-2.91-2.48-0.99-0.42
Non GAAP EPS
-3.12-2.92N/AN/AN/A
 
Statistics
Profit Margin
-1701.55%-8112.89%N/AN/AN/A
Operating Profit Margin
-1897.64%-8540.72%N/AN/AN/A

All data in USD

Charts